ArticleBritish journal of cancer2014

Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway.

S Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.